Corporate DisclosureORIONPHARM
ORIONPHARM Corporate Disclosure — 30 April 2025
Announcement summary
- What happened
- ORIONPHARM published a corporate disclosure on 30 April 2025. Read the full announcement for details.
- Company
- Orion Pharma Ltd.
- Announcement published
Original announcement
(Continuation news of ORIONPHARM): Consolidated NAV per share (excluding Revaluation Surplus) was Tk. 81.42 as on March 31, 2025 and Tk. 84.27 as on June 30, 2024. NAV per share (including Revaluation Surplus) was Tk. 89.18 as on March 31, 2025 and Tk. 92.05 as on June 30, 2024. (end)
Bangla translation
A Bangla translation is under review because critical figures or dates did not match the English disclosure.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 68119f147463ac9d44253cc9
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from ORIONPHARM
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.